HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)

structure given in first source
Also Known As:
h89; H 87; H 89; H-87; H-89; H-89 dihydrochloride hydrate; protein kinase A inhibitor H89
Networked: 201 relevant articles (11 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bettaieb, Ali: 3 articles (01/2022 - 03/2015)
2. Sharifzadeh, Mohammad: 3 articles (08/2017 - 01/2012)
3. Khodagholi, Fariba: 3 articles (10/2015 - 01/2012)
4. Cheng, Yu-Tong: 3 articles (09/2013 - 10/2010)
5. Li, Xiang-Dong: 3 articles (09/2013 - 10/2010)
6. Yang, Yue-Jin: 3 articles (09/2013 - 10/2010)
7. Zhang, Hai-Tao: 3 articles (09/2013 - 10/2010)
8. Zhao, Jing-Lin: 3 articles (09/2013 - 10/2010)
9. Paul, Catherine: 2 articles (01/2022 - 03/2015)
10. Racoeur, Cindy: 2 articles (01/2022 - 03/2015)

Related Diseases

1. Memory Disorders (Memory Loss)
2. Infarction (Infarctions)
3. Neoplasms (Cancer)
4. Hypoxia (Hypoxemia)
5. Ischemia

Related Drugs and Biologics

1. protein kinase modulator
2. Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
3. KN 93
4. Calcium-Calmodulin-Dependent Protein Kinase Type 2
5. U 0126 (UO 126)
6. KT 5720
7. chelerythrine
8. 1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)
9. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
10. Brain-Derived Neurotrophic Factor (BDNF)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Salvage Therapy
4. Radiotherapy
5. Vagus Nerve Stimulation